Pinealon Peptide

Pinealon (Glu-Asp-Arg) is a short bioregulatory tripeptide from Professor Khavinson laboratory, derived from pineal gland extracts. Research demonstrates neuroprotective effects through modulation of gene expression in brain cortex cells, antioxidant enzyme upregulation, and regulation of melatonin synthesis pathways.

Pinealon (Glu-Asp-Arg) is a short bioregulatory tripeptide developed within the Khavinson family of cytogenic peptides. Its low molecular weight (418.40 g/mol) and lack of secondary structure allow it to traverse biological membranes and, importantly, the blood-brain barrier, where it is hypothesised to exert direct effects on neuronal gene expression. Unlike receptor-binding ligands such as classical neuropeptides, Pinealon is proposed to act via epigenetic and transcriptional modulation, binding to specific double-stranded DNA sequences in promoter regions of genes involved in neurogenesis, antioxidant defence, and circadian regulation.

DNA-Binding and Gene Expression

In vitro studies using fluorescence-labelled Pinealon have demonstrated that the tripeptide enters the nucleus of cultured neurons and binds to specific CpG-rich promoter regions. This binding has been associated with altered expression of genes encoding serotonin N-acetyltransferase (AANAT), tryptophan hydroxylase, and components of the antioxidant response element (ARE) pathway. The result is a modulation of melatonin biosynthesis machinery and upregulation of cellular defences against oxidative stress.

Antioxidant and Anti-Apoptotic Pathways

Preclinical work indicates Pinealon reduces reactive oxygen species (ROS) accumulation in neurons exposed to hypoxic, hyperhomocysteinemic, or excitotoxic insults. Mechanistically, this is linked to increased activity of superoxide dismutase (SOD) and catalase, alongside a reduction in caspase-3 activation. By suppressing the intrinsic apoptotic cascade, Pinealon appears to preserve neuronal viability in cortical and hippocampal cultures challenged with prooxidant agents such as hydrogen peroxide or homocysteic acid.

Circadian and Pineal Modulation

As its name implies, Pinealon was originally derived from research on the pineal gland. It is hypothesised to support pineal cell function by maintaining expression of enzymes required for nocturnal melatonin synthesis. In aged animal models, where pineal melatonin output declines, Pinealon administration has been associated with partial restoration of circadian amplitude and improved entrainment to light-dark cycles.

Comparison to Related Khavinson Peptides

Pinealon is structurally and functionally related to other short Khavinson bioregulators such as Epithalon (Ala-Glu-Asp-Gly) and Cortagen (Ala-Glu-Asp-Pro). While Epithalon is primarily studied for telomerase activation and longevity endpoints, Pinealon's research profile emphasises acute neuroprotection and cognitive performance under stress. The tripeptide's smaller size compared with tetrapeptides like Epithalon may confer different pharmacokinetic and tissue-distribution properties, although direct comparative data remain limited.

Collectively, the proposed mechanism positions Pinealon as a multifunctional epigenetic modulator whose effects converge on neuronal resilience, redox homeostasis, and circadian signalling rather than a single receptor-mediated cascade.

Pinealon is a synthetic linear tripeptide composed of three standard L-amino acids in the sequence glutamic acid–aspartic acid–arginine. Its small size, polar character, and absence of disulfide bonds simplify handling and reconstitution relative to larger peptides. The following table summarises the verified physicochemical properties relevant to research use.

The peptide is hygroscopic in its lyophilized form and should be protected from atmospheric moisture. Because it contains no methionine, tryptophan, or cysteine residues, Pinealon is not particularly susceptible to oxidative degradation, which contributes to its relative stability in solution compared with sulfur-containing peptides. The arginine residue provides a single basic site, while the two acidic residues (Glu, Asp) confer overall negative charge at physiological pH — a property thought to facilitate interaction with positively charged DNA-binding pockets.

Pinealon (Glu-Asp-Arg) is supplied as a sterile lyophilized powder and must be reconstituted prior to use in laboratory studies. Because the tripeptide is highly water soluble and lacks disulfide bridges, handling is straightforward, but standard aseptic technique and careful concentration calculation remain essential for reproducible experimental work.

Recommended Reconstitution Protocol

1. Equilibrate the vial to room temperature for 20-30 minutes after removal from -20°C storage to prevent condensation on the lyophilized cake.
2. Select a diluent. Bacteriostatic water for injection (0.9% benzyl alcohol) is standard for multi-dose research use; sterile water for injection or 0.9% sodium chloride may be substituted for single-use preparations.
3. Calculate target concentration. A common working stock is 5 mg/mL (e.g., 10 mg Pinealon + 2 mL diluent). For low-dose studies, dilute the stock further in sterile saline immediately before use.
4. Inject diluent slowly down the inner wall of the vial using a sterile syringe, avoiding direct streams onto the powder.
5. Allow passive dissolution by gently swirling the vial. Do not shake or vortex; mechanical agitation can generate foam and damage peptide integrity even though Pinealon lacks disulfide bridges.
6. Inspect the solution. Properly reconstituted Pinealon is a clear, colorless solution with no visible particulates.
7. Aliquot into low-binding polypropylene tubes if multiple freeze-thaw cycles are anticipated.

Compound-Specific Notes

• The arginine residue contributes a positive charge at physiological pH, while glutamate and aspartate carry negative charges, producing a net amphoteric peptide with an isoelectric point near neutrality and excellent aqueous solubility.
• Pinealon contains no methionine or cysteine, eliminating concerns about oxidation or disulfide scrambling that complicate handling of larger peptides.
• Avoid repeated freeze-thaw cycles of reconstituted material; degradation kinetics for short bioregulatory peptides accelerate after the third cycle.
• For intranasal research formulations described in the Khavinson literature, sterile saline at 1 mg/mL is the typical vehicle.
• Document the reconstitution date on the vial label to track in-use stability.

This material is sold strictly for in vitro and preclinical laboratory research. It is not intended for human or veterinary use, and all handling should occur under appropriate institutional biosafety guidelines.

Proper storage is critical to preserving the structural integrity and biological activity of Pinealon throughout the course of a research program. As a short tripeptide composed of standard L-amino acids without modifications, Pinealon is more stable than many larger peptides, but it remains susceptible to hydrolysis, microbial contamination, and bond rearrangement under suboptimal conditions.

Lyophilized Powder Storage

• Long-term storage: Store sealed lyophilized vials at -20°C in a frost-free freezer, protected from light. Under these conditions Pinealon retains full potency for at least 24 months.
• Short-term storage: Refrigeration at 2-8°C is acceptable for up to 30 days when frequent access is required.
• Transit: The lyophilized form tolerates ambient temperatures for 7-14 days during shipping without measurable loss of activity, owing to the low water content of the cake.

Reconstituted Solution Storage

• Once reconstituted with bacteriostatic water, store at 2-8°C and use within 14-21 days.
• For longer-term storage of reconstituted material, aliquot into low-binding tubes and freeze at -20°C or -80°C. Avoid more than two freeze-thaw cycles.
• Protect from prolonged light exposure; while Pinealon lacks aromatic chromophores that drive photodegradation, ambient light can still accelerate buffer-mediated hydrolysis.

Stability Considerations

• The Glu-Asp-Arg backbone is resistant to oxidation because it contains no methionine, cysteine, or tryptophan residues.
• The principal degradation pathway is enzymatic hydrolysis of the peptide bonds, which is negligible at -20°C but accelerates at room temperature in aqueous solution.
• Avoid storing reconstituted Pinealon in glass containers for extended periods, as charged peptides can adsorb to glass surfaces and reduce effective concentration.
• Document each freeze-thaw cycle and inspect solutions for cloudiness, precipitation, or color change before use.

Adhering to these storage recommendations ensures reproducible experimental results across the lifetime of the vial and aligns with standard practice for Khavinson family bioregulatory peptides.